Sprott and HennighThe price of NFG was north of $8 US when the assay discrepancy news came out. NFG sold off and then traded for a few days in the low $6's and upper $5's while the market worked to figure out what it thought. The pattern was beginning to break to the upside yesterday when we got the news confirming the Sprott financing is going forward. That news advanced the change in pricing pattern which had really already begun. As a result, for the first time in a few days, NFG closed at the highs of the day instead of the lows.
Today, Crescat should broadcast its podcast at 2:00 Eastern. Assuming Quinton Hennigh addresses the assay discrepancy issue in a positive way, any remaining concern over the assay issue will likely disipate quickly. However, given the lateness in the trading day of the podcast, and the fact that it's Friday, the reaction may not be apparent until early next week.
I'm not predicting it, but I personally won't be surprised to see NFG trading north of $7.50 US by Wednesday of next week, if not perhaps even sooner.